Literature DB >> 19005626

Heightened incidence of sporadic Creutzfeldt-Jakob disease is associated with a shift in clinicopathological profiles.

Katharina Stoeck1, Klaus Hess, Lorenz Amsler, Tobias Eckert, Dieter Zimmermann, Adriano Aguzzi, Markus Glatzel.   

Abstract

Incidences of human transmissible spongiform encephalopathies are monitored by national registries in the majority of countries in Western Europe. During the past 13 years incidences for Creutzfeldt-Jakob disease (CJD) in Switzerland fluctuated between 0.4 and 2.63 cases/10(6) inhabitants. We have compared clinicpathological patient profiles including geographic and gender distribution, age at disease onset, duration of disease, clinical symptoms, and recognized or hypothetical risk factors for CJD, genetic risk factors, biochemical and histopathological data for two cohorts of Swiss sporadic CJD patients from years of regular sporadic CJD incidence (1996-2000, mean incidence 1.3 cases/10(6) inhabitants, n = 47) to Swiss sporadic CJD patients from years of elevated sporadic CJD incidence (2001-2004, mean incidence 2.3 cases/10(6) inhabitants, n = 73). Sporadic CJD patients from the cohort with elevated sporadic CJD incidence presented with a higher frequency of rare sporadic CJD subtypes. Patients of these subtypes were significantly older and showed a skewed male/female ratio when compared to published patients of identical sporadic CJD-types or to patients from the 1996-2000 cohort and indicates that improved detection of rare sporadic CJD subtypes may have contributed to increased incidence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005626     DOI: 10.1007/s00415-008-0900-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  32 in total

Review 1.  Shattuck lecture--neurodegenerative diseases and prions.

Authors:  S B Prusiner
Journal:  N Engl J Med       Date:  2001-05-17       Impact factor: 91.245

2.  Classification of sporadic Creutzfeldt-Jakob disease revisited.

Authors:  Ignazio Cali; Rudolph Castellani; Jue Yuan; Amer Al-Shekhlee; Mark L Cohen; Xiangzhu Xiao; Francisco J Moleres; Piero Parchi; Wen-Quan Zou; Pierluigi Gambetti
Journal:  Brain       Date:  2006-09       Impact factor: 13.501

3.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

4.  Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants.

Authors:  I Zerr; W J Schulz-Schaeffer; A Giese; M Bodemer; A Schröter; K Henkel; H J Tschampa; O Windl; A Pfahlberg; B J Steinhoff; O Gefeller; H A Kretzschmar; S Poser
Journal:  Ann Neurol       Date:  2000-09       Impact factor: 10.422

5.  Incidence of Creutzfeldt-Jakob disease in Switzerland.

Authors:  Markus Glatzel; Colette Rogivue; Azra Ghani; Johannes R Streffer; Lorenz Amsler; Adriano Aguzzi
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

6.  Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease.

Authors:  Bernhard J Steinhoff; Inga Zerr; Maya Glatting; Walter Schulz-Schaeffer; Sigrid Poser; Hans A Kretzschmar
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

7.  Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings.

Authors:  B Meissner; K Körtner; M Bartl; U Jastrow; B Mollenhauer; A Schröter; M Finkenstaedt; O Windl; S Poser; H A Kretzschmar; I Zerr
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

8.  A new variant of Creutzfeldt-Jakob disease in the UK.

Authors:  R G Will; J W Ironside; M Zeidler; S N Cousens; K Estibeiro; A Alperovitch; S Poser; M Pocchiari; A Hofman; P G Smith
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

9.  Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease.

Authors:  R J Castellani; M Colucci; Z Xie; W Zou; C Li; P Parchi; S Capellari; M Pastore; M H Rahbar; S G Chen; P Gambetti
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

10.  Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study.

Authors:  Mark W Head; Diane Ritchie; Nadine Smith; Victoria McLoughlin; William Nailon; Sazia Samad; Stephen Masson; Matthew Bishop; Linda McCardle; James W Ironside
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

View more
  4 in total

1.  Racial and ethnic differences in individuals with sporadic Creutzfeldt-jakob disease in the United States of America.

Authors:  Brian S Appleby; Tonya D Rincon-Beardsley; Kristin K Appleby; Mitchell T Wallin
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

2.  Creutzfeldt-Jakob disease mortality in Canada, 1998 to 2013.

Authors:  M B Coulthart; G H Jansen; T Connolly; R D'Amour; J Kruse; J Lynch; S Sabourin; Z Wang; A Giulivi; M N Ricketts; N R Cashman
Journal:  Can Commun Dis Rep       Date:  2015-08-06

3.  A case-control study of sporadic Creutzfeldt-Jakob disease in Switzerland: analysis of potential risk factors with regard to an increased CJD incidence in the years 2001-2004.

Authors:  Jessica Ruegger; Katharina Stoeck; Lorenz Amsler; Thomas Blaettler; Marcel Zwahlen; Adriano Aguzzi; Markus Glatzel; Klaus Hess; Tobias Eckert
Journal:  BMC Public Health       Date:  2009-01-14       Impact factor: 3.295

4.  A nationwide trend analysis in the incidence and mortality of Creutzfeldt-Jakob disease in Japan between 2005 and 2014.

Authors:  Yoshito Nishimura; Ko Harada; Toshihiro Koyama; Hideharu Hagiya; Fumio Otsuka
Journal:  Sci Rep       Date:  2020-09-23       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.